F. Lundmark, Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis, Nat. Genet, vol.39, pp.1108-1113, 2007.

S. G. Gregory, Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis, Nat. Genet, vol.39, pp.1083-1091, 2007.

D. A. Hafler, Risk alleles for multiple sclerosis identified by a genomewide study, N. Engl. J. Med, vol.357, pp.851-862, 2007.

J. A. Todd, Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes, Nat. Genet, vol.39, pp.857-864, 2007.

P. Concannon, S. S. Rich, and G. T. Nepom, Genetics of type 1A diabetes, N. Engl. J. Med, vol.360, pp.1646-1654, 2009.

C. A. Anderson, Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47, Nat. Genet, vol.43, pp.246-252, 2011.

C. O'doherty, I. Alloza, M. Rooney, and K. Vandenbroeck, IL7RA polymorphisms and chronic inflammatory arthropathies, Tissue Antigens, vol.74, pp.429-431, 2009.

X. Wang, Interleukin-7 receptor single nucleotide polymorphismrs 6897932 (C/T) and the susceptibility to systemic lupus erythematosus, Inflammation, vol.37, pp.615-620, 2014.

S. Hoffjan, Analysis of variation in the IL7RA and IL2RA genes in atopic dermatitis, J. Dermatol. Sci, vol.55, pp.138-140, 2009.

M. Heron, Variation in IL7R predisposes to sarcoid inflammation, Genes Immun, vol.10, pp.647-653, 2009.

C. L. Mackall, T. J. Fry, and R. E. Gress, Harnessing the biology of IL-7 for therapeutic application, Nat. Rev. Immunol, vol.11, pp.330-342, 2011.

R. Mazzucchelli and S. K. Durum, Interleukin-7 receptor expression: intelligent design, Nat. Rev. Immunol, vol.7, pp.144-154, 2007.

W. Liu, CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells, J. Exp. Med, vol.203, pp.1701-1711, 2006.

N. Seddiki, Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells, J. Exp. Med, vol.203, pp.1693-1700, 2006.

L. Michel, Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis, J. Clin. Invest, vol.118, pp.3411-3419, 2008.

Y. Rochman, R. Spolski, and W. Leonard, New insights into the regulation of T cells by gamma(c) family cytokines, Nat. Rev. Immunol, vol.9, pp.480-490, 2009.

C. A. Mcelroy, J. A. Dohm, and S. T. Walsh, Structural and biophysical studies of the human IL-7/IL-7Ralpha complex, Structure, vol.17, pp.54-65, 2009.

C. A. Mcelroy, Structural reorganization of the interleukin-7 signaling complex, Proc. Natl Acad. Sci. USA, vol.109, pp.2503-2508, 2012.

S. T. Walsh, Structural insights into the common ?-chain family of cytokines and receptors from the interleukin-7 pathway, Immunol. Rev, vol.250, p.303, 2012.

F. Carrette and C. Surh, IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis, Semin. Immunol, vol.24, pp.209-217, 2012.

M. Watanabe, Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa, J. Exp. Med, vol.187, pp.389-402, 1998.

T. Totsuka, IL-7 Is essential for the development and the persistence of chronic colitis, J. Immunol, vol.178, pp.4737-4748, 2007.

T. Shinohara, Upregulated IL-7 receptor ? expression on colitogenic memory CD4+ T cells may participate in the development and persistence of chronic colitis, J. Immunol, vol.186, pp.2623-2632, 2011.

M. Uehira, The development of dermatitis infiltrated by gamma delta T cells in IL-7 transgenic mice, Int. Immunol, vol.5, pp.1619-1627, 1993.

M. Uehira, H. Matsuda, A. Nakamura, and H. Nishimoto, Immunologic abnormalities exhibited in IL-7 transgenic mice with dermatitis, J. Invest. Dermatol, vol.110, pp.740-745, 1998.

T. Adachi, Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma, Nat. Med, vol.21, pp.1272-1279, 2015.

L. Lee, Anti-IL-7 receptor-? reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function, Proc. Natl Acad. Sci. USA, 2012.

C. Penaranda, IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells, Proc. Natl. Acad. Sci. USA, 2012.

L. Lee, IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-? in multiple sclerosis, Sci. Transl. Med, vol.3, pp.93-68, 2011.

B. R. Lawson, Interleukin-7 is required for CD4+ T cell activation and autoimmune neuroinflammation, Clin. Immunol, vol.161, pp.260-269, 2015.

S. A. Hartgring, Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators, Arthritis Rheum, vol.62, pp.2716-2725, 2010.

S. A. Hartgring, Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7 ? induced immune activation in rheumatoid arthritis, Arthritis Rheum, vol.60, pp.2595-2605, 2009.

J. A. Van-roon, Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis, Ann. Rheum. Dis, vol.66, pp.664-669, 2007.

M. Yamazaki, Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis, J. Immunol, vol.171, pp.1556-1563, 2003.

R. Gonzalez-quintial, Systemic autoimmunity and lymphoproliferation are associated with excess IL-7 and inhibited by IL-7R? blockade, PLoS ONE, vol.6, p.27528, 2011.

J. Jin, T. Kawai, S. Cha, and Q. Yu, Interleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in mice, Arthritis Rheum, vol.65, pp.2132-2142, 2013.

H. Mai, IL-7 receptor blockade following T cell depletion promotes long-term allograft survival, J. Clin. Invest, vol.124, pp.1723-1733, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02167811

G. Piotti, J. Ma, E. Adams, S. Cobbold, and H. Waldmann, Guiding postablative lymphocyte reconstitution as a route toward transplantation tolerance, Am. J. Transplant, vol.14, pp.1678-1689, 2014.

H. Dooms, Interleukin-7: Fuel for the autoimmune attack, J. Autoimmun, vol.45, pp.40-48, 2013.

U. Von-freeden-jeffry, Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine, J. Exp. Med, vol.181, pp.1519-1526, 1995.

J. J. Peschon, Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice, J. Exp. Med, vol.180, pp.1955-1960, 1994.

J. Dunham, Blockade of CD127 exerts a dichotomous clinical effect in marmoset experimental autoimmune encephalomyelitis, J. Neuroimmune. Pharmacol, vol.11, pp.73-83, 2016.

J. Silva, O. Vetterlein, J. Jose, S. Peters, and H. Kirby, The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation, J. Biol. Chem, vol.290, pp.5462-5469, 2015.

K. B. Lewis, Comparison of the ability of wild type and stabilized human IgG(4) to undergo Fab arm exchange with endogenous IgG(4)in vitro and in vivo, Mol. Immunol, vol.46, pp.3488-3494, 2009.

N. Poirier, Selective CD28 Antagonist Blunts Memory Immune Responses and Promotes Long-Term Control of Skin Inflammation in Nonhuman Primates, J. Immunol, vol.196, pp.274-283, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02150299

N. Poirier, Antibody-mediated depletion of lymphocyte-activation gene3 (LAG-3(+))-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates, Clin. Exp. Immunol, 2011.

B. Kern, W. Li, C. Bono, L. Lee, and E. Kraynov, Receptor occupancy and blocking of STAT5 signaling by an anti-IL-7 receptor ? antibody in cynomolgus monkeys, Cytom. B Clin. Cytom, vol.90, pp.191-198, 2016.

D. Vignali and P. Monti, Targeting homeostatic T cell proliferation to control beta-cell autoimmunity, Curr. Diab. Rep, vol.16, p.40, 2016.

P. Deshpande, IL-7-and IL-15-mediated TCR sensitization enables T cell responses to self-antigens, J. Immunol, vol.190, pp.1416-1423, 2013.

H. E. Fleming and C. J. Paige, Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinasedependent pathway, Immunity, vol.15, pp.521-531, 2001.

S. Liu, S. Jiang, C. Li, B. Zhang, and Q. Li, miR-17-92 cluster targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation, J. Biol. Chem, 2014.

B. Shulgin, G. Helmlinger, and Y. Kosinsky, A generic mechanism for enhanced cytokine signaling via cytokine-neutralizing antibodies, PLoS ONE, vol.11, p.149154, 2016.

J. Wijdenes, Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic antigp130 monoclonal antibodies, Eur. J. Immunol, vol.25, pp.3474-3481, 1995.

D. Finch, Identification of a potent anti-IL-15 antibody with opposing mechanisms of action in vitro and in vivo, Br. J. Pharmacol, vol.162, pp.480-490, 2011.

B. Vanhove, Selective blockade of CD28 and not CTLA-4 with a singlechain Fv-alpha1-antitrypsin fusion antibody, Blood, vol.102, pp.564-570, 2003.

M. Konopleva, Z. Estrov, S. Zhao, M. Andreeff, and K. Mehta, Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells, J. Immunol, vol.161, pp.4702-4708, 1998.

M. Angin, Gene transfer of human CD40Ig does not prevent rejection in a non-human primate kidney allotransplantation model, Transpl. Immunol, vol.27, pp.139-145, 2012.

M. Dokmanovic and W. J. Wu, Trastuzumab-induced HER2 phosphorylation: exploring the mechanisms and implications, Receptors Clinical Investigation, vol.1, 2014.

K. Verstraete, Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma, Nat. Commun, vol.8, p.14937, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01605011

B. J. Ganguly, An IL-7 Receptor Blocking Antibody Increases the Ratio of Tregs to Effector Memory T Cells (TEM) and Increases PD-1 Expression on T Cell Subsets in the Peripheral Blood of Patients with Type 1 Diabetes, 2016.

J. Geginat, F. Sallusto, and A. Lanzavecchia, Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4+ T cells, J. Exp. Med, vol.194, pp.1711-1720, 2001.

A. Puel, S. F. Ziegler, R. H. Buckley, and W. J. Leonard, Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency, Nat. Genet, vol.20, pp.394-397, 1998.

R. Wang and D. R. Green, Metabolic checkpoints in activated T cells, Nat. Immunol, vol.13, pp.907-915, 2012.

J. A. Wofford, H. L. Wieman, S. R. Jacobs, Y. Zhao, and J. Rathmell, IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival, Blood, vol.111, pp.2101-2111, 2008.

B. T. Walters, A. Ricciuti, L. Mayne, and S. W. Englander, Minimizing back exchange in the hydrogen exchange-mass spectrometry experiment, J. Am. Soc. Mass. Spectrom, vol.23, pp.2132-2139, 2012.

J. J. Trombetta, Preparation of Single-Cell RNA-Seq Libraries for Next Generation Sequencing, Curr. Protoc. Mol. Biol, vol.107, 2014.

C. Trapnell, Differential gene and transcript expression analysis of RNAseq experiments with TopHat and Cufflinks, Nat. Protoc, vol.7, pp.562-578, 2012.

C. W. Law, Y. Chen, W. Shi, and G. K. Smyth, voom: precision weights unlock linear model analysis tools for RNA-seq read counts, Genome Biol, vol.15, p.29, 2014.
DOI : 10.1186/gb-2014-15-2-r29
URL : https://genomebiology.biomedcentral.com/track/pdf/10.1186/gb-2014-15-2-r29

N. Poirier, Selective CD28 antagonist prevents Aldara-induced skin inflammation in non-human primates, Exp. Dermatol, 2015.
DOI : 10.1111/exd.12891
URL : https://hal.archives-ouvertes.fr/inserm-02150253